文献速递呼吸道感染呼吸危重症与机械通气

机械循环支持治疗流感病毒相关心肌炎所致难治性心源性休克

Mechanical circulatory support in refractory cardiogenic shock due to influenza virus-related myocarditis.
PubMed 文献 · Eur Respir J · 2020-09-03

本研究基于HACURE前瞻性观察性注册研究,分析两个流感季节中7例流感相关心肌炎合并难治性心源性休克并接受VA-ECMO联合Impella(ECMELLA概念)机械循环支持的患者,并与倾向性评分匹配的AMI或DCM相关难治性心源性休克患者比较。结果显示流感相关难治性心源性休克患者30天死亡率显著更高,所有患者入院18天内死亡。

要点

  • 流感相关心肌炎合并难治性心源性休克患者即使接受联合机械循环支持,全部在入院18天内死亡。
  • 与AMI或DCM相关难治性心源性休克相比,流感相关者30天死亡率显著更高。
  • 所有患者均未接种流感疫苗,提示疫苗接种可能存在保护意义。

核心结论

  • 尽管联合机械循环支持使流感相关心肌炎合并难治性心源性休克患者获得初步稳定,但休克恶化过程未能逆转,所有患者均死亡。
  • 流感病毒感染可能对心脏以外其他器官造成严重影响,导致机械循环支持无法代偿的不可逆终末器官损伤,从而造成毁灭性结局。

研究设计与样本

  • 前瞻性、观察性分析,来自单中心HAnnover心脏卸载注册研究(HACURE),覆盖两个近期流感流行季。
  • 分析7例确诊流感相关心肌炎合并难治性心源性休克并接受机械循环支持的ICU患者,并进行倾向性评分匹配与AMI或DCM相关难治性心源性休克患者比较。

主要发现

  • 7例患者平均年龄56±10岁,58%为男性,流感A型2例、B型5例。
  • 所有患者流感季节前均未接种疫苗。
  • 机械循环支持采用VA-ECMO联合Impella微轴流泵;2例院外心脏骤停患者VA-ECMO用于体外心肺复苏。
  • 所有患者入院18天内死亡。
  • 倾向性评分匹配比较显示,流感相关难治性心源性休克患者30天死亡率显著高于AMI或DCM相关者。

临床怎么用

  • 对于流感相关心肌炎合并难治性心源性休克,联合机械循环支持虽可初步稳定血流动力学,但预后极差,需警惕不可逆多器官损伤。
  • 应重视流感疫苗接种以预防流感相关心肌炎及其严重后果。

局限性

  • 单中心观察性研究,样本量小(仅7例流感相关患者),结论外推受限。
  • 非随机设计,倾向性评分匹配仅能控制部分混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is scarce evidence for mechanical circulatory support (MCS) in patients with influenza-related myocarditis complicated by refractory cardiogenic shock (rCS). We sought to investigate the impact of MCS using combined veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and micro-axial flow pumps (the ECMELLA concept) in influenza-related myocarditis complicated by rCS. METHODS: This is a prospective, observational analysis from the single centre HAnnover Cardiac Unloading REgistry (HACURE) from two recent epidemic influenza seasons. We analysed patients with verified influenza-associated myocarditis complicated by rCS who were admitted to our intensive care unit (ICU) on MCS. Subsequently, we performed a propensity score (PS) matched analysis to patients with acute myocardial infarction (AMI) complicated by rCS and non-ischaemic cardiomyopathy (DCM) related rCS. RESULTS: We describe a series of seven patients with rCS-complicated influenza-related myocarditis (mean age 56±10 years, 58% male, influenza A (n=2)/influenza B (n=5)). No patient had been vaccinated prior to the influenza season. MCS was provided using combined VA-ECMO and Impella micro-axial flow pump. In two patients with out-of-hospital cardiac arrest, VA-ECMO had been implanted for extracorporeal cardiopulmonary resuscitation. All patients died within 18 days of hospital admission. By PS-based comparison to patients with AMI- or DCM-related rCS and combined MCS, 30-day mortality was significantly higher in influenza-related rCS. CONCLUSION: Despite initial stabilisation with combined MCS in patients with rCS-complicated influenza-related myocarditis, the detrimental course of shock could not be stopped and all patients died. Influenza virus infection potentially critically affects other organs besides the heart, leading to irreversible end-organ damage that MCS cannot compensate for and, therefore, results in a devastating outcome.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Sieweke JT, Akin M, Stetskamp S, et al. Mechanical circulatory support in refractory cardiogenic shock due to influenza virus-related myocarditis. Eur Respir J. 2020. PMID: 32398305. doi:10.1183/13993003.00925-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。